Main content start
Huseyin Naci is an Associate Professor in the Department of Health Policy at the London School of Economics. His research evaluates the quantity and quality of the evidence base underpinning the approval, adoption, reimbursement, and use of new drugs in Europe and the US. This research has appeared in leading medical and health policy journals, including JAMA, The Lancet, The BMJ, Health Affairs, and The Milbank Quarterly.
His 2013 article with John Ioannidis comparing the mortality benefits of drug and non-drug interventions for common chronic conditions was selected as one of the “Five key BMJ research papers to mark the decade.”